September 16,2023,Kuala Lumpur – Sunsuria Healthcare, and Icon Cancer Centre, have entered into a strategic partnership to elevate the standard of cancer care for Malaysians, under a joint-venture entity, Icon Sunsuria Sdn Bhd (“Icon Sunsuria”)
Icon Sunsuria aims to provide access to quality cancer care and improve the well-being of patients and their families, by establishing cancer centres across Malaysia via strategic partnerships with local healthcare operators.
Sunsuria Healthcare is a subsidiary of Sunsuria Berhad, and Icon Cancer Centre is an integral arm of global cancer care provider, Icon Group.
Audrey Ooi, CEO of Sunsuria Healthcare, and Serena Wee, CEO of Icon ASEAN and Hong Kong, signed the partnership agreement witnessed by Dr. Zaliha Mustafa, together with Tan Sri Datuk Ter Leong Yap, Founder and Executive Chairman of Sunsuria Berhad, and Dr Patricia Kho, Medical Director of Icon Cancer Centre at Mt Alvernia.
Also presence at the signing ceremony were Dr Steven Barraclough, Visiting Senior Government Official of Department of Foreign Affairs and Trade (DFAT), Australian High Commission in Malaysia and Melanie Harris, Trade and Investment Commissioner to Malaysia and Brunei at the Australian Trade and Investment Commission (AUSTRADE).
“Efforts such as these complement the Ministry’s own action plan for battling cancer, as outlined in the Malaysian National Strategic Plan for Cancer Control Program 2021-2025. In addition to improving the health of cancer survivors from diagnosis through to treatment, we welcome future-facing solutions that align with our strategic goals to address the country’s cancer research needs and strengthen our medical pool of talent,” said Dr. Zaliha Mustafa, Minister of Health Malaysia, at the signing ceremony for the landmark partnership.
“The joint venture between Sunsuria Healthcare and Icon Group is a strategic partnership that will play a significant part in shaping the future of the healthcare sector in Malaysia. It is another example of the strong bilateral ties and confidence both Australia and Malaysia share, bringing mutual benefit to both economies,” said Melanie Harris, Trade and Investment Commissioner to Malaysia and Brunei.
Tan Sri Datuk Ter said, “Sunsuria Berhad takes pride in its proactive role in nation-building, which encompasses various facets such as job creation, knowledge transfer, attracting international investments, and fostering community development in Malaysia.
“Our approach involves forging exclusive partnerships that combine global expertise such as our partnership with Icon, supported with our local knowledge and network. We are on a new journey to further our vision by merging technology and knowledge transfer, much like our accomplishments in the field of education with Xiamen University Malaysia from China and Concord College International School from the United Kingdom.”
According WHO, Malaysia saw an estimated 48,639 new cases of cancer in 2020, with number of cases expected to double by 2040.
Leveraging Icon Cancer Centre’s long-standing excellence in oncology and deep network of clinical expertise, the joint-venture will enrich the capability of hospitals’ existing medical services with specialised cancer expertise and enable patients to access comprehensive cancer care and cutting-edge treatments.
Icon Group, with Icon Cancer Centre as a key component, delivers a comprehensive spectrum of services including medical oncology, radiation oncology, haematology, pharmacy, and chemotherapy compounding.
Icon Group is Australia’s leading integrated cancer care provider, with global footprint over 50 cancer centres across Australia, New Zealand, Mainland China, Hong Kong, Singapore and Vietnam. Icon Cancer Centre will bring clinical expertise and extensive healthcare leadership as majority shareholder of Icon Sunsuria, working alongside Sunsuria Healthcare as its trusted Malaysian partner.